Edward O’Mara

2.1k total citations
46 papers, 1.6k citations indexed

About

Edward O’Mara is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Edward O’Mara has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 12 papers in Pediatrics, Perinatology and Child Health and 11 papers in Oncology. Recurrent topics in Edward O’Mara's work include HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (11 papers) and Pharmaceutical studies and practices (6 papers). Edward O’Mara is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (11 papers) and Pharmaceutical studies and practices (6 papers). Edward O’Mara collaborates with scholars based in United States, Netherlands and Canada. Edward O’Mara's co-authors include Stephen D. Hall, Lei Ma, Gopal Krishna, Jack Gorski, D. I. Jones, Mitchell A. Hamman, Monika Martinho, Richard A. Preston, M. Martinho and Dennis M. Grasela and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Edward O’Mara

46 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edward O’Mara United States	21	668	505	369	268	247	46	1.6k
Polina German United States	20	905 1.4×	425 0.8×	174 0.5×	280 1.0×	424 1.7×	36	1.9k
Bradley M. Kerr United States	16	285 0.4×	192 0.4×	375 1.0×	226 0.8×	153 0.6×	24	1.4k
Jessica Cusato Italy	27	1.1k 1.6×	560 1.1×	128 0.3×	222 0.8×	411 1.7×	164	2.6k
John Tjia United Kingdom	17	725 1.1×	177 0.4×	332 0.9×	203 0.8×	88 0.4×	23	1.3k
Corinne Isnard Bagnis France	28	642 1.0×	445 0.9×	128 0.3×	236 0.9×	173 0.7×	127	2.9k
Manoli Vourvahis United States	21	502 0.8×	224 0.4×	334 0.9×	444 1.7×	71 0.3×	55	1.4k
Anita Mathias United States	27	1.4k 2.1×	708 1.4×	344 0.9×	504 1.9×	700 2.8×	65	2.6k
Lorena Baietto Italy	27	826 1.2×	349 0.7×	102 0.3×	182 0.7×	227 0.9×	61	1.6k
Anne‐Marie Taburet France	26	1.5k 2.2×	406 0.8×	180 0.5×	222 0.8×	137 0.6×	74	2.1k
Juan J.L. Lertora United States	24	399 0.6×	222 0.4×	210 0.6×	185 0.7×	114 0.5×	49	1.7k

Countries citing papers authored by Edward O’Mara

Since Specialization

Citations

This map shows the geographic impact of Edward O’Mara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward O’Mara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward O’Mara more than expected).

Fields of papers citing papers by Edward O’Mara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward O’Mara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward O’Mara. The network helps show where Edward O’Mara may publish in the future.

Co-authorship network of co-authors of Edward O’Mara

This figure shows the co-authorship network connecting the top 25 collaborators of Edward O’Mara. A scholar is included among the top collaborators of Edward O’Mara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward O’Mara. Edward O’Mara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Liangxian, Arthur Branstrom, John D. Baird, et al.. (2017). PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells. Blood. 130. 1371–1371. 1 indexed citations

Li, Yan, Xiaomin Wang, Edward O’Mara, et al.. (2017). Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function. Clinical Pharmacology Advances and Applications. Volume 9. 133–145. 10 indexed citations

Shapiro, Geoffrey I., Jon Infante, Todd M. Bauer, et al.. (2016). Initial first-in-human phase 1 results of PTC596, a novel small molecule that targets cancer stem cells (CSCs) by reducing BMI1 protein levels. Annals of Oncology. 27. vi122–vi122. 2 indexed citations

Liu, Liangang, et al.. (2016). A Phase 1, double-blind, 4-period crossover study to investigate the effects of pomalidomide on QT interval in healthy male subjects. Cancer Chemotherapy and Pharmacology. 77(2). 251–258. 5 indexed citations

Hulskotte, Ellen G. J., R. Douglas Bruce, Hwa-ping Feng, et al.. (2015). Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy. European Journal of Clinical Pharmacology. 71(3). 303–311. 13 indexed citations

Kersemaekers, Wendy M., Thijs van Iersel, U. K. Nässander, et al.. (2014). Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects. Antimicrobial Agents and Chemotherapy. 59(2). 1246–1251. 56 indexed citations

Hulskotte, Ellen G. J., Hwa-ping Feng, Fengjuan Xuan, et al.. (2012). Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir. Clinical Infectious Diseases. 56(5). 718–726. 58 indexed citations

Treitel, Michelle, Thomas Marbury, Richard A. Preston, et al.. (2012). Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function. Clinical Pharmacokinetics. 51(9). 619–628. 34 indexed citations

Hulskotte, Ellen G. J., Samir K. Gupta, Fengjuan Xuan, et al.. (2012). Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers. Hepatology. 56(5). 1622–1630. 78 indexed citations

10.

Krishna, Gopal, et al.. (2011). Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers. Expert Opinion on Drug Metabolism & Toxicology. 8(1). 1–10. 35 indexed citations

11.

Kasserra, Claudia, et al.. (2011). Effect of Vicriviroc With or Without Ritonavir on Oral Contraceptive Pharmacokinetics: A Randomized, Open-Label, Parallel-Group, Fixed-Sequence Crossover Trial in Healthy Women. Clinical Therapeutics. 33(10). 1503–1514. 12 indexed citations

12.

Kasserra, Claudia, Angela Sansone‐Parsons, Anther Keung, et al.. (2010). Renal Insufficiency Has No Effect on the Pharmacokinetics of Vicriviroc in a Ritonavir-Containing Regimen. Clinical Pharmacokinetics. 49(6). 397–406. 5 indexed citations

13.

Marino, Maria R., et al.. (2006). The Effect of Ravuconazole on the Pharmacokinetics of Nelfinavir in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 46(2). 193–200. 11 indexed citations

14.

Friedland, Gerald, Laurie Andrews, Michael Child, et al.. (2005). Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction. AIDS. 19(15). 1635–1641. 39 indexed citations

15.

Noor, Mustafa A., Rex A. Parker, Edward O’Mara, et al.. (2004). The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults. AIDS. 18(16). 2137–2144. 155 indexed citations

16.

Drusano, George L., John A. Bilello, Sandra L. Preston, et al.. (2001). Hollow‐Fiber Unit Evaluation of a New Human Immunodeficiency Virus Type 1 Protease Inhibitor, BMS‐232632, for Determination of the Linked Pharmacodynamic Variable. The Journal of Infectious Diseases. 183(7). 1126–1129. 44 indexed citations

17.

Thornton, Alice, Edward O’Mara, Thomas J. Hiltke, et al.. (1998). Prevention of ExperimentalHaemophilus ducreyiInfection: A Randomized, Controlled Clinical Trial. The Journal of Infectious Diseases. 177(6). 1608–1613. 27 indexed citations

18.

Cookson, Susan Temporado, Melanie Ihrig, Edward O’Mara, Alan I. Hartstein, & William R. Jarvis. (1998). Use of an Estimation Method to Derive an Appropriate Denominator to Calculate Central Venous Catheter-Associated Bloodstream Infection Rates. Infection Control and Hospital Epidemiology. 19(1). 28–31. 9 indexed citations

19.

Jones, David R., et al.. (1996). Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation*. Clinical Pharmacology & Therapeutics. 60(4). 374–384. 58 indexed citations

20.

O’Mara, Edward, et al.. (1996). Delayed Onset of Angioedema with Angiotensin‐Converting Enzyme Inhibitors: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(4). 675–679. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact